GHDx
Published on GHDx (https://ghdx.healthdata.org)


The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients

General Info

Geography 
China (CHN)
Beijing, Chongqing, Fujian, Guangdong, Guizhou, Hebei, Henan, Hunan, Inner Mongolia, Jiangsu, Jiangxi, Liaoning, Shaanxi, Shandong, Shanghai, Shanxi, Sichuan, Tianjin, Xinjiang, Zhejiang
Time period covered 
January, 1999 - December, 2004
Data type
Scientific literature
Keywords 
Cardiovascular and circulatory diseases, Ischemic heart disease, Stroke

Citation

Authors 
Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A, FEVER Study Group
Journal 
J Hypertens
Pages 
2157-72
Publication year 
2005
Suggested citation 
Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A, FEVER Study Group. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens. 2005; 23(12): 2157-72.

Source URL:https://ghdx.healthdata.org/record/felodipine-event-reduction-fever-study-randomized-long-term-placebo-controlled-trial-chinese